Literature DB >> 10996380

HLA-G suppresses proliferation of CD4(+) T-lymphocytes.

D R Bainbridge1, S A Ellis, I L Sargent.   

Abstract

HLA-G is a non-classical MHC class 1 molecule, expressed primarily on human foetal trophoblast cells, which exhibits almost no genetic polymorphism. Because of these unusual features, HLA-G has been suggested to help prevent maternal immune attack of the semi-allogeneic foetus. The aim of these experiments was to investigate the effects of HLA-G on T-lymphocyte responses by using MHC class II-bearing HLA-G transfectants as stimulators of a mixed lymphocyte reaction. The presence of HLA-G, but not classical HLA class I, on the surface of stimulator cells markedly suppressed thymidine incorporation by peripheral blood mononuclear responder cells from a class I-similar, class II-dissimilar male. The suppressive effect of HLA-G on the mixed lymphocyte reaction persisted after depletion of phagocytes and CD8(+) T-cells from the responder population, but the mixed lymphocyte reaction was entirely abolished by depletion of CD4(+) T-cells. These results suggest that HLA-G exerts a direct suppressive effect on CD4(+) T-lymphocytes, even in the absence of the CD8(+) cells with which other human MHC class I molecules are thought to interact. Thus, HLA-G may allow the foetus to escape maternal immune attack by modulating CD4(+) T-cell activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996380     DOI: 10.1016/s0165-0378(00)00070-x

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  54 in total

1.  Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism.

Authors:  N Lila; N Rouas-Freiss; J Dausset; A Carpentier; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

Authors:  Thomas Vauvert F Hviid; Sine Hylenius; Christina Rørbye; Lone G Nielsen
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

3.  Competitive binding effects on surface-enhanced Raman scattering of peptide molecules.

Authors:  Leo Seballos; Nicole Richards; Daniel J Stevens; Mira Patel; Laura Kapitzky; Scott Lokey; Glenn Millhauser; Jin Z Zhang
Journal:  Chem Phys Lett       Date:  2007-10       Impact factor: 2.328

Review 4.  New aspects in celiac disease.

Authors:  M I Torres; M A López Casado; A Ríos
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

5.  Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma.

Authors:  Simon Jasinski-Bergner; Christine Stoehr; Juergen Bukur; Chiara Massa; Juliane Braun; Stefan Hüttelmaier; Verena Spath; Roland Wartenberg; Wolfgang Legal; Helge Taubert; Sven Wach; Bernd Wullich; Arndt Hartmann; Barbara Seliger
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

Review 6.  Pregnancy and rheumatoid arthritis: insights into the immunology of fetal tolerance and control of autoimmunity.

Authors:  Shreyasee Amin; Erik J Peterson; Ann M Reed; Daniel L Mueller
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

7.  Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites.

Authors:  Pierre Lau; Claire Amadou; Hélène Brun; Virginie Rouillon; Fiona McLaren; Anne-France Le Rolle; Margaret Graham; Geoffrey W Butcher; Etienne Joly
Journal:  BMC Immunol       Date:  2003-07-01       Impact factor: 3.615

8.  Soluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes.

Authors:  Fabio Morandi; Vito Pistoia
Journal:  Int Immunol       Date:  2012-12-05       Impact factor: 4.823

Review 9.  Soluble HLA-G: Are they clinically relevant?

Authors:  Vito Pistoia; Fabio Morandi; Xinhui Wang; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2007-07-31       Impact factor: 15.707

10.  Impact of HLA-G in the outcome of vitiligo in Tunisian patients.

Authors:  Akrem Jalel; Aouadi Ridha; Duboisier Laurent; Moureaux Philippe; M H Hamdaoui
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.